Nubundle Acquires OnTrack Software and Adds Chief Medical Advisor to Executive Team

Nubundle, a digital fertility coaching and medication management service for fertility clinics, announced today that it has acquired the exclusive license to OnTrack. Developed at the University of Michigan by Dr. Michael Lanham, M.D., the former Medical Director of the fertility practice, OnTrack is software that allows fertility clinics to help more patients by automating patient reminders, medication supply, and reporting, ultimately improving outcomes and increasing clinic staff efficiency.

Additionally, Dr. Michael Lanham, a board-certified Reproductive Endocrinologist, joins Nubundle as its Chief Medical Advisor.

Read this here.:

https://jessicapressreleases.blogspot.com/2018/05/toysrus-liquidation-and-early-easter.html

Due to the increased expectations from modern, tech-savvy patients, fertility clinics need robust tools to help reduce patient churn and avoid staff burnout. With Nubundle, its clinic partners are able to create a more personalized and positive patient experience through:

It's reported that up to 15 percent of in-vitro fertilization (IVF) cycles are complicated by medication adherence related issues. Traditionally, clinics have little real-time insight into a patient's medication inventory or their adherence to time-critical medication administrations, making it hard to provide crucial support for patients tasked with administering a complex array of medications in which timing and dosage are critical to a successful pregnancy.

"The goal of fertility treatments like IVF is always a healthy baby, but due to the complexity of these treatments, it can be a long journey to get to that point. One major factor in the success of these procedures is the lack of access that fertility clinics have to efficient communication and education channels to support patients outside the office. Patient volumes are increasing without an increasing number of clinic staff, but patients expect clinics to provide the same high-quality communication and guidance," said Dr. Lanham M.D., Chief Medical Advisor at Nubundle. "With Nubundle and OnTrack, we're disrupting the antiquated processes clinics have in place to connect with patients, especially when it comes to medication management, providing the clinics with insights never before possible."

Continue reading.:

https://jessicapressreleases.blogspot.com/2018/04/pixel-film-studios-unveils-pro3rd.html

In his role as Chief Medical Advisor, Dr. Lanham M.D., provides strategic insight around research, product design and clinic relationship management for Nubundle. He received his medical degree from and did his residency and fellowship training at the University of Michigan. He is now an Assistant Professor in the Department of Learning Health Sciences at the University.

"Our vision for Nubundle goes beyond just providing education and direction to people on their parenthood journey. We are creating technology that makes us the modern partner for fertility clinics, helping seamlessly enhance patient engagement, management and communication – and of course helping more families grow," said John Ciasulli, CEO and co-founder of Nubundle. "We're excited to have Dr. Lanham join our team to make this next step a success. His knowledge of the market and medical expertise is invaluable to our future innovation."

Nubundle and Dr. Lanham are currently leading a clinical trial with OnTrack that will be completed by the end of 2019.

For more information, please visit clinics.nubundle.com.

About Nubundle
Nubundle provides fertility focused patient engagement solutions to providers in high touch, high stress medical environments. Nubundle's fertility coaching and medication management software enable clinics to scale, helping more patients while operating more efficiently. More info here.

About University of Michigan
The University of Michigan spends over $1.5 billion per year on its wide-ranging research initiatives, making it one of the largest, most successful academic research institutions in the world. U-M Tech Transfer works to transfer the resulting research discoveries to business and venture partners, resulting in the launch of 22 new companies and the signing of over 230 new licenses last year alone. These activities have led to the launch of over 100 new start-up companies since 2000, including May Mobility, Compendia Biosciences and Arbor Networks, and the adoption of several world-changing technologies, such as the FluMist® inhalable flu vaccine and the IntraLase® LASIK eye surgery system. More on U-M Tech Transfer, including a up-to-date list of technologies available for commercialization, can be found at the U-M Tech Transfer website.

.

© Copy Right 2019 Jessica Brown's Press Releases.

All information are taken from the news source. We do not promise anything nor take any responsibility for anything the news owner claim. We just share the news as is. You can contact news owner directly in the message for more information.